Value in Health

Title Publication Date Language Citations
Universal Health Coverage: A Quest for All Countries But under Threat in Some2013/01/01English73
Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) Measure2010/12/01English72
Economic Costs of Influenza-Related Work Absenteeism2003/03/01English72
Methods for the Collection of Resource Use Data within Clinical Trials: A Systematic Review of Studies Funded by the UK Health Technology Assessment Program2010/12/01English72
Implementing Patient-Reported Outcome Measures in Clinical Breast Cancer Care: A Systematic Review2019/10/01English72
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I2010/01/01English72
A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report [1]2018/02/01English71
Ten-Year Survival and Cost Following Breast Cancer Recurrence: Estimates from SEER-Medicare Data2008/03/01English71
Comparison of Different Valuation Methods for Population Health Status Measured by the EQ-5D in Three European Countries2009/07/01English71
Valuation of EQ-5D Health States in Poland: First TTO-Based Social Value Set in Central and Eastern Europe2010/03/01English71
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA2019/01/01English71
The Routine Collation of Health Outcomes Data from Hospital Treated Subjects in the Health Outcomes Data Repository (HODaR): Descriptive Analysis from the First 20,000 Subjects2005/09/01English70
An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England: A Policy Modeling Study2014/07/01English70
Costs of Care for Dementia Patients in Community Setting: An Analysis for Mild and Moderate Disease Stage2011/09/01English70
Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations2007/11/01English70
Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective2016/09/01English70
Factors Influencing Cost-Related Nonadherence to Medication in Older Adults: A Conceptually Based Approach2010/06/01English70
Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective2018/11/01English69
Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group2018/05/01English69
A Trial-Based Assessment of the Cost-Utility of Bevacizumab and Chemotherapy versus Chemotherapy Alone for Advanced Non-Small Cell Lung Cancer2011/09/01English69
Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group2019/02/01English69
Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility2007/05/01English69
Outcome Measurement in Clinical Genetics Services: A Systematic Review of Validated Measures2008/05/01English68
Estimating Preference-Based Single Index Measures for Dementia Using DEMQOL and DEMQOL-Proxy2012/03/01English68
Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations?2005/01/01English68
Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group2020/06/01English68
Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes2017/02/01English68
EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom2018/01/01English67
Constrained Optimization Methods in Health Services Research—An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force2017/03/01English67
A Review of the Cost of Atrial Fibrillation2012/03/01English67